Alteration of myoepithelial cells during botulinum toxin type A‐inhibited salivary secretion

Abstract

AbstractObjectiveIntraglandular injection of botulinum toxin type A (BoNT/A) effectively treats sialorrhea. Myoepithelial cells (MECs) are essential for salivary secretion. The role of MECs in BoNT/A‐inhibited salivary secretion, and its underlying mechanisms remain unknown.Materials and MethodsBoNT/A was injected into rat submandibular glands (SMGs). At 1, 2, 4, 8, and 12 weeks postinjection, salivary flow rate of SMGs was measured. Electron microscopy, immunohistochemistry, immunofluorescence, and Western blot analysis were used to detect morphological and functional changes in MECs and chemical denervation in SMGs.ResultsBoNT/A temporarily decreased salivary secretion in rat SMGs and this inhibitory effect lasted 4 weeks. During the inhibitory period, MECs atrophied and expressed reduced α‐smooth muscle actin (α‐SMA), vimentin, and phosphorylated myosin light chain 2 (p‐MLC2), suggesting that BoNT/A attenuated MEC contractility. Furthermore, BoNT/A cleaved synaptosome‐associated protein 25 (SNAP‐25) and decreased the expression and activity of acetylcholinesterase (AChE), indicating that BoNT/A‐induced chemical parasympathetic denervation of SMGs by cleaving SNAP‐25.ConclusionsBoNT/A temporarily caused MEC atrophy and decreased MEC contractility in rat SMGs, which contributed to reversible inhibition of salivary secretion. The underlying mechanisms involved temporary parasympathetic denervation caused by SNAP‐25 cleavage. These findings provide new insights into the mechanisms of BoNT/A‐inhibited salivary secretion.